Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial (Q42633443)
Jump to navigation
Jump to search
scientific article published on April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial |
scientific article published on April 2012 |
Statements
1 reference
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial (English)
1 reference
Edith A Perez
1 reference
Winston W Tan
1 reference
Jacob B Allred
1 reference
Muhammad Salim
1 reference
Patrick Flynn
1 reference
Paul A S Fishkin
1 reference
Philip J Stella
1 reference
Martin Wiesenfeld
1 reference
Albert M Bernath
1 reference
Tom R Fitch
1 reference
1 April 2012
1 reference
1 reference
81-86
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference